Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Tabuk Pharmaceuticals (Cardiovascular Therapy Products)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

3 medicine products in the cardiovascular therapy area in Saudi Arabia, the Gulf Countries, North Africa and the Middle East excluding Morocco, Sudan and Algeria.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Thurgauerstrasse 36/38
  • 8050 Zurich
  • Switzerland

Tabuk Pharmaceuticals (Cardiovascular Therapy Products) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Tabuk Pharmaceuticals (Cardiovascular Therapy Products)‘s full profile, request access.

Request full access to PitchBook

Tabuk Pharmaceuticals (Cardiovascular Therapy Products) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Tabuk Pharmaceuticals (Cardiovascular Therapy Products)‘s full profile, request access.

Request full access to PitchBook